Contact Us close
Contact Details

Please fill out all required fields.

Contact Preferences

Menu
  • Blog
  • Medtronic Products
  • Support
  • Education and Training
arrow_drop_down
Contact Us

The PRODIGY Trial

PRODIGY (PRediction of Opioid‐induced respiratory Depression In patients monitored by capnoGraphY) is a prospective, multi‐center, international cohort study to assess the potential for respiratory compromise (RC) risk assessment in patients receiving opioids on the hospital general care floor also examining the value of continuous capnography and oximetry monitoring.

Info Sheet: PRODIGY Study on Respiratory Compromise

Download Now
  • Infographic: PRODIGY Study Highlights
    Download Now
  • Info Sheet: PRODIGY FAQ Short Version
    Download Now
  • Guide: PRODIGY Risk Assessment Tool Interactive PDF
    Download Now
  • Interviews on Respiratory Compromise
    Watch Now
  • Video: Evidence Summary of PRODIGY Study
    Learn More
  • PRODIGY Podcast
    Learn More
  • Explore Remote Continuous Monitoring Solutions

    Learn More
  • White Paper: Patient Monitoring The Joint Commission R3 And PRODIGY Score
    Download Now
  • Video: Evidence Summary PRODIGY Seeking Answers
    Watch Now
  • Infographic: PRODIGY Economics Secondary Study
    Download Now
  • Share
  • Mail
  • Facebook
  • Twitter
  • LinkedIn
  • Close
  • Our Company
  • Careers
  • Order Products (open in new window)
  • Product Manuals (open in new window)
  • Contact & Support
Engineering the extraordinary
  • Facebook
  • Twitter
  • Youtube
  • Linkedin
  • Privacy Statement
  • Terms of Use
  • Accessibility Statement
Operational Headquarters 710 Medtronic Parkway, Minneapolis, MN 55432-5640 USA

US-NA-2300080: 2023-03

©2023 Medtronic